Biogen Inc., 10% Owner at SANGAMO THERAPEUTICS, INC (SGMO), sold 162,974 shares at $8.55 ($1.4M) on 2021-12-23, disclosed to the SEC on 2021-12-28.
Open-market sale of $1.4M SGMO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.55 | 81,187 | $694K | 49.8% |
| 2 | $8.55 | 81,187 | $694K | 49.8% |
| 3 | $8.56 | 600 | $5K | 0.4% |
| Total | $8.55 avg | 162,974 | $1.4M | 100% |
| Filing → |
| SGMO | SELL | 2021-12-30 | $24K | — | Filing → |
| SGMO | SELL | 2021-12-10 | $405K | — | Filing → |
| SGMO | SELL | 2021-12-09 | $2.2M | — | Filing → |